Skip to content
healthcare.dev
Get a free key

HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)

NDC 63833-829, HUMAN C1-ESTERASE INHIBITOR, kit, from CSL Behring GmbH.

Product NDC
63833-829
Status
Listed
Labeler
CSL Behring GmbH
Dosage form
KIT
Route
—
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125606
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63833-829 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
63833-829-02638330829021 KIT in 1 CARTON (63833-829-02) * 5.6 mL in 1 VIAL, SINGLE-USE (63833-839-01) * 5.6 mL in 1 VIAL, SINGLE-USE (63833-765-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63833-829 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63833-829 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63833-829. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.